½ÃÀ庸°í¼­
»óǰÄÚµå
1346848

¼¼°èÀÇ MRI Á¶¿µÁ¦ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2030³â)

Global MRI Contrast Media Agents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 192 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

MRI Á¶¿µÁ¦(MRI Contrast Media Agents) ½ÃÀå ¼ö¿ä´Â 2022³â 29¾ï 8,000¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 55¾ï 8,000¸¸ ´Þ·¯ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ÀÎ 2023-2030³â CAGRÀº 8.15%·Î ÃßÀÌÇÏ¸ç ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶¿µÁ¦¶ó°íµµ ÇÏ´Â MRI(ÀÚ±â°ø¸í¿µ»ó) Á¶¿µÁ¦´Â ½Åü ³» ƯÁ¤ Á¶Á÷°ú ±¸Á¶ÀÇ °¡½Ã¼ºÀ» ³ôÀ̱â À§ÇØ MRI ½Ã¼ú Áß¿¡ »ç¿ëµÇ´Â ¹°ÁúÀÔ´Ï´Ù. Á¶¿µÁ¦¸¦ ü³»¿¡ ÁÖÀÔÇÏ¸é ¼­·Î ´Ù¸¥ Á¶Á÷ °£ÀÇ ´ëºñ¸¦ ´õ °­ÇÏ°Ô ¸¸µé¾î ƯÁ¤ ºÎÀ§ÀÇ ½Ã°¢È­¸¦ µ½°í MRIÀÇ Áø´Ü Á¤È®µµ¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

MRI Á¶¿µÁ¦ ½ÃÀåÀº Á¤¹ÐÇÑ Áø´Ü ¿µ»ó¿¡ ´ëÇÑ ¼ö¿ä, ±â¼ú ¹ßÀü, ¿µ»ó ÃÔ¿µÀÌ ÇÊ¿äÇÑ ÁúȯÀÇ À¯º´·ü Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Á¶¿µÁ¦´Â MRI ½ºÄµ ½Ã ƯÁ¤ Á¶Á÷ÀÇ °¡½Ã¼ºÀ» Çâ»ó½ÃÄÑ Á¤È®ÇÑ Áø´Ü°ú °³¼±µÈ Ä¡·á °èȹÀ¸·Î À̾îÁý´Ï´Ù. ºñħ½ÀÀû ¿µ»ó ÀýÂ÷¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ÀÓ»ó °¡À̵å¶óÀο¡ Á¶¿µ Áõ°­ MRI°¡ ÅëÇյǸ鼭 ½ÃÀå ¼ºÀåÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀº À̹ÌÁö ǰÁú, ¾ÈÀü¼º ¹× ȯÀÚ Ä¡·á °á°ú °³¼±¿¡ ±â¿©ÇÕ´Ï´Ù. Àα¸ °í·ÉÈ­¿Í ¸¸¼º ÁúȯÀÇ ³ôÀº ¹ßº´·ü·Î ÀÎÇØ ÀæÀº ÃÔ¿µÀÌ ÇÊ¿äÇØÁö¸é¼­ Á¶¿µÁ¦¿¡ ´ëÇÑ ¼ö¿ä´Â ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸´Â ¾ÈÀü ¹®Á¦¸¦ ÇØ°áÇϰí ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ´õ ¾ÈÀüÇϰí È¿À²ÀûÀÎ Á¶¿µÁ¦¸¦ °³¹ßÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ Á¤È®ÇÑ ¿µ»ó°ú ȯÀÚ Áß½É Ä¡·á¸¦ ¿ì¼±½ÃÇÔ¿¡ µû¶ó ƯÈ÷ ÀÇ·á ÀÎÇÁ¶ó°¡ ¼ºÀåÇÏ´Â ½ÅÈï ½ÃÀåÀ» Áß½ÉÀ¸·Î MRI ½ºÄµ¿¡¼­ Á¶¿µÁ¦ Ȱ¿ëÀÌ È®´ëµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´ë»óÀ¸·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀï ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ µµ±¸´Â MRI Á¶¿µÁ¦ ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. MRI Á¶¿µÁ¦ »ê¾÷ ¼ºÀå ¹× µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±ÙÀ» Á¦°øÇÕ´Ï´Ù.

Áö¿ª ºÐ¼® :

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾Æ ÅÂÆò¾ç, ³²¹Ì ¹× Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ MRI Á¶¿µÁ¦ ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼­ °³º° ¿ëµµ ºÎ¹®¿¡ ´ëÇÑ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÁßÁ¡À» µÓ´Ï´Ù.

¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖ´Â °æ¿ì ´ç»ç¿¡ ¹®ÀÇÇϼ¼¿ä. ´ç»çÀÇ ¿¬±¸Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ÇöȲ

Á¦3Àå MRI Á¶¿µÁ¦-»ê¾÷ ºÐ¼®

  • ¼Ò°³ : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø ¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦ ¿äÀÎ
  • ½ÃÀå ±âȸ
  • »ê¾÷ µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀå ¸Å·Âµµ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸ñ·Ï
    • ¿øÀç·á Á¦Á¶»ç ¸ñ·Ï
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ±¸¸ÅÀÚ ¸ñ·Ï
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå MRI Á¶¿µÁ¦ ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • Á¦Ç°º° °³¿ä
  • ½ÇÀû ¹× ¿¹Ãø µ¥ÀÌÅÍ
  • Á¦Ç°º° ºÐ¼®
  • »óÀÚ¼º ¿¡ÀÌÀüÆ®
  • ÃÊ»óÀÚ¼º ¿¡ÀÌÀüÆ®

Á¦6Àå MRI Á¶¿µÁ¦ ½ÃÀå ºÐ¼® : À¯Çüº°

  • À¯Çüº° °³¿ä
  • ½ÇÀû ¹× ¿¹Ãø µ¥ÀÌÅÍ
  • À¯Çüº° ºÐ¼®
  • ÀÓ»ó¿ë
  • ÀüÀÓ»ó

Á¦7Àå MRI Á¶¿µÁ¦ ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ¿ëµµº° °³¿ä
  • ½ÇÀû ¹× ¿¹Ãø µ¥ÀÌÅÍ
  • ¿ëµµº° ºÐ¼®
  • ¼ÒÈ­±â
  • Á¤¸Æ³»
  • °£ ´ãÁó
  • ½Å°æ ¿µ»ó
  • ±âŸ

Á¦8Àå MRI Á¶¿µÁ¦ ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

  • ÃÖÁ¾ ¿ëµµº° °³¿ä
  • ½ÇÀû ¹× ¿¹Ãø µ¥ÀÌÅÍ
  • ÃÖÁ¾ ¿ëµµº° ºÐ¼®
  • º´¿ø
  • À̹Ì¡ ¼¾ÅÍ

Á¦9Àå MRI Á¶¿µÁ¦ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼Ò°³
  • ºÏ¹Ì ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾Æ ÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • ¾Æ½Ã¾Æ ÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾Æ ÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾Æ ÅÂÆò¾ç
  • ³²¹Ì ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • ³²¹Ì : ºÎ¹®º°
    • ³²¹Ì : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä« °øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå MRI Á¶¿µÁ¦ ±â¾÷ °æÀï ±¸µµ

  • MRI Á¶¿µÁ¦ ½ÃÀå °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç° Ãâ½Ã
  • ±âŸ °³¹ß

Á¦11Àå ±â¾÷ °³¿ä

  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • GE Healthcare
  • Bayer AG
  • Guerbet GmbH
  • Bracco Imaging Spa
  • Vitalquan LLC
  • Miltenyi Biotec BV&Co. Kg
LYJ 23.10.11

The global demand for MRI Contrast Media Agents Market is presumed to reach the market size of nearly USD 5.58 BN by 2030 from USD 2.98 BN in 2022 with a CAGR of 8.15% under the study period 2023 - 2030.

MRI (Magnetic Resonance Imaging) contrast media agents, also known as contrast agents, are substances used during MRI procedures to enhance the visibility of specific tissues and structures within the body. Contrast media agents are introduced into the body to create a stronger contrast between different tissues, aiding in the visualization of certain areas and improving the diagnostic accuracy of the MRI.

MARKET DYNAMICS:

The MRI Contrast Media Agents market is expanding due to factors such as the demand for precise diagnostic imaging, technological advancements, and the increasing prevalence of medical conditions requiring imaging. Contrast media agents enhance the visibility of specific tissues during MRI scans, leading to accurate diagnoses and improved treatment planning. The rising demand for non-invasive imaging procedures and the incorporation of contrast-enhanced MRI in clinical guidelines drive market growth. Technological innovations contribute to improved image quality, safety, and patient outcomes. The ageing population and the higher incidence of chronic diseases necessitate frequent imaging, further fueling the demand for contrast media agents. Ongoing research focuses on developing safer and more efficient agents to address safety concerns and improve patient outcomes. As healthcare providers prioritize accurate imaging and patient-centric care, the utilization of contrast media agents in MRI scans is poised to expand, particularly in emerging markets with growing healthcare infrastructure.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mri contrast media agents. The growth and trends of mri contrast media agents industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the mri contrast media agents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Paramagnetic Agents
  • Superparamagnetic Agents

By Type

  • Clinical
  • Preclinical

By Application

  • Gastrointestinal
  • Intravenous
  • Hepatobiliary
  • Neurological Imaging
  • Others

By End-Use

  • Hospitals
  • Imaging Centers

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the MRI Contrast Media Agents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the MRI Contrast Media Agents market include GE Healthcare, Bayer AG, Guerbet GmbH, Bracco Imaging Spa, Vitalquan, LLC, Miltenyi Biotec B.V. & Co. Kg. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MRI CONTRAST MEDIA AGENTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Paramagnetic Agents Historic and Forecast Sales by Regions
  • 5.5 Superparamagnetic Agents Historic and Forecast Sales by Regions

6 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Clinical Historic and Forecast Sales by Regions
  • 6.5 Preclinical Historic and Forecast Sales by Regions

7 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Gastrointestinal Historic and Forecast Sales by Regions
  • 7.5 Intravenous Historic and Forecast Sales by Regions
  • 7.6 Hepatobiliary Historic and Forecast Sales by Regions
  • 7.7 Neurological Imaging Historic and Forecast Sales by Regions
  • 7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY END-USE

  • 8.1 Overview by End-use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-use
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Imaging Centers Historic and Forecast Sales by Regions

9 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE MRI CONTRAST MEDIA AGENTS COMPANIES

  • 10.1. Mri Contrast Media Agents Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF MRI CONTRAST MEDIA AGENTS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. GE Healthcare
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Bayer AG
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Guerbet GmbH
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Bracco Imaging Spa
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Vitalquan LLC
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Miltenyi Biotec B.V. & Co. Kg
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦